Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

AZD9668

2 x 30 mg oral tablets twice daily (bid) for 12 weeks

DRUG

Placebo

2 x matched placebo to oral tablet twice daily (bid) for 12 weeks

Trial Locations (9)

Research Site, Kingston

Research Site, Québec

Research Site, Hellerup

Research Site, Hvidovre

Research Site, Odensec

Research Site, Breda

Research Site, Nieuwegein

Research Site, Bucharest

Research Site, Kyiv